QLYS Form 4: Director sale of 200 shares under 10b5-1 plan
Rhea-AI Filing Summary
Wendy Pfeiffer, a director of Qualys, Inc. (QLYS), sold 200 shares of company common stock on 08/15/2025 at $129.72 per share. The Form 4 reports that after the sale she beneficially owned 11,082 shares, held directly. The filing states the sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2025. The Form 4 was submitted on 08/18/2025 and signed under power of attorney by Bruce Posey.
Positive
- Sale executed under a Rule 10b5-1 trading plan, indicating a pre-established, documented trading arrangement
- Complete post-transaction disclosure: the filing reports the transaction date, price, and that 11,082 shares remain beneficially owned
- Timely Form 4 submission with signature executed by power of attorney on 08/18/2025
Negative
- None.
Insights
TL;DR: Small director sale executed under a pre-established 10b5-1 plan; holdings remain disclosed.
The reported sale of 200 shares at $129.72 is explicitly described as occurring under a Rule 10b5-1 trading plan adopted on February 21, 2025. The transaction reduced direct holdings to 11,082 shares. This is a routine disclosure that documents compliance with insider-trading safe-harbor procedures rather than a material change to ownership. No derivative transactions or additional securities classes are reported.
TL;DR: Disclosure shows proper use of a documented 10b5-1 plan and timely Form 4 reporting.
The Form 4 clearly states the sale was effected pursuant to a documented 10b5-1 plan, which supports procedural compliance with Section 16 reporting requirements. The filing includes the required details: transaction date, price, post-transaction beneficial ownership and a power-of-attorney signature. There are no indications of undisclosed related-party transactions or amendments in this filing.